Detalhe da pesquisa
1.
Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death.
Mol Ther
; 31(3): 701-714, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523165
2.
CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer.
Mol Ther
; 31(11): 3193-3209, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735875
3.
Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice.
Mol Ther
; 29(1): 60-74, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010818
4.
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer.
J Natl Cancer Inst
; 111(4): 409-418, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30203099
5.
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma.
Front Pharmacol
; 9: 1118, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30327605
6.
Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Biomed Pharmacother
; 84: 1783-1791, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27899251